A detailed history of Great West Life Assurance CO transactions in Exelixis, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 286,810 shares of EXEL stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
286,810
Previous 224,505 27.75%
Holding current value
$10.3 Million
Previous $5.05 Million 47.55%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.96 - $27.6 $1.37 Million - $1.72 Million
62,305 Added 27.75%
286,810 $7.45 Million
Q2 2024

Aug 12, 2024

BUY
$20.34 - $23.73 $1.07 Million - $1.25 Million
52,833 Added 30.78%
224,505 $5.05 Million
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $1.08 Million - $1.29 Million
-53,782 Reduced 23.85%
171,672 $4.07 Million
Q4 2023

Feb 13, 2024

SELL
$19.25 - $24.13 $167,051 - $209,400
-8,678 Reduced 3.71%
225,454 $5.4 Million
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $199,824 - $238,656
10,495 Added 4.69%
234,132 $5.11 Million
Q2 2023

Aug 10, 2023

SELL
$18.17 - $20.48 $520,279 - $586,424
-28,634 Reduced 11.35%
223,637 $4.28 Million
Q1 2023

May 12, 2023

SELL
$16.3 - $19.41 $60,424 - $71,952
-3,707 Reduced 1.45%
252,271 $4.9 Million
Q4 2022

Feb 10, 2023

BUY
$14.96 - $17.39 $630,938 - $733,423
42,175 Added 19.73%
255,978 $4.11 Million
Q3 2022

Nov 01, 2022

BUY
$15.68 - $22.27 $3.35 Million - $4.76 Million
213,803 New
213,803 $3.35 Million
Q2 2022

Aug 09, 2022

BUY
$17.44 - $23.16 $460,067 - $610,960
26,380 Added 15.4%
197,666 $4.12 Million
Q1 2022

May 12, 2022

BUY
$17.03 - $22.67 $203,355 - $270,702
11,941 Added 7.49%
171,286 $3.99 Million
Q4 2021

Feb 14, 2022

BUY
$15.84 - $21.88 $187,593 - $259,124
11,843 Added 8.03%
159,345 $2.91 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $421,322 - $546,426
25,848 Added 21.25%
147,502 $3.14 Million
Q2 2021

Aug 11, 2021

BUY
$17.95 - $25.56 $15,221 - $21,674
848 Added 0.7%
121,654 $2.22 Million
Q1 2021

May 17, 2021

SELL
$20.53 - $25.22 $168,366 - $206,829
-8,201 Reduced 6.36%
120,806 $2.73 Million
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $295,637 - $398,684
-16,076 Reduced 11.08%
129,007 $2.59 Million
Q3 2020

Nov 17, 2020

SELL
$20.67 - $26.94 $543,414 - $708,252
-26,290 Reduced 15.34%
145,083 $3.55 Million
Q3 2020

Nov 13, 2020

BUY
$20.67 - $26.94 $375,284 - $489,122
18,156 Added 11.85%
171,373 $4.19 Million
Q2 2020

Aug 17, 2020

SELL
$16.46 - $27.42 $77,592 - $129,257
-4,714 Reduced 2.98%
153,217 $3.64 Million
Q1 2020

May 14, 2020

BUY
$14.46 - $21.8 $178,942 - $269,775
12,375 Added 8.5%
157,931 $2.71 Million
Q4 2019

Feb 11, 2020

SELL
$15.15 - $18.89 $4.56 Million - $5.69 Million
-301,281 Reduced 67.43%
145,556 $2.56 Million
Q3 2019

Oct 25, 2019

SELL
$17.68 - $22.65 $763,369 - $977,959
-43,177 Reduced 8.81%
446,837 $7.92 Million
Q2 2019

Jul 31, 2019

BUY
$18.93 - $24.75 $5.17 Million - $6.76 Million
273,249 Added 126.06%
490,014 $0
Q1 2019

May 08, 2019

BUY
$19.6 - $24.76 $705,266 - $890,939
35,983 Added 19.9%
216,765 $5.15 Million
Q4 2018

Feb 12, 2019

BUY
$13.65 - $21.8 $139,120 - $222,185
10,192 Added 5.97%
180,782 $3.3 Million
Q3 2018

Nov 13, 2018

BUY
$15.87 - $22.4 $2.2 Million - $3.11 Million
138,700 Added 434.93%
170,590 $3.02 Million
Q2 2018

Aug 10, 2018

SELL
$18.56 - $22.45 $51,615 - $62,433
-2,781 Reduced 8.02%
31,890 $687,000
Q3 2017

Nov 09, 2017

BUY
$23.35 - $29.24 $809,567 - $1.01 Million
34,671
34,671 $838,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.